Dr. Fernando Xavier Cuascut, MD

Dr. Cuascut practices at Plains Memorial Hospital in Houston, Texas.

Dr. Cuascut's NPI, 1134531692, was assigned on June 2, 2014. Dr. Cuascut graduated from University of Puerto Rico, Medical Sciences Campus in 2014. Dr. Cuascut holds Texas license S1380.

Dr. Cuascut's primary practice is Plains Memorial Hospital, at 7200 Cambridge St, Houston, TX 77030 in Harris County. The practice phone is (806) 647-2191.

Dr. Cuascut's primary practice is Plains Memorial Hospital in Houston, Texas. Dr. Cuascut is also affiliated with Baylor St. Luke's Medical Center. The medical group on file is Baylor Medicine. Dmand AI also links Dr. Cuascut to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cuascut practices. Vendor and product names are available with a free account.

Neurology is Dr. Cuascut's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Cuascut is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Cuascut is licensed in Texas.

Dmand AI lists multiple sclerosis among the conditions Dr. Cuascut treats.

CMS data shows 4,011 Medicare services from Dr. Cuascut across 13 procedure codes in 2024, for 193 Medicare patients. Medicare paid $81,015 for them. Every service was in an office.

CMS counts 193 Medicare patients who saw Dr. Cuascut in 2024. The largest group is 65 to 74, with 91 patients. 70% of them have high cholesterol, and 69% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cuascut's median patient age at 50, with 70% women.

In 2024, Dr. Cuascut wrote 1,414 Medicare Part D claims for 124 patients. 88% of them were for generic drugs. CMS names the drug for 1,238 of them, across 25 drugs with 11 or more claims each, at $1,631,542 in total drug cost. In 2023, CMS named 1,135 claims across 26 drugs.

Dmand AI links 13 papers to Dr. Cuascut, published from 2019 to 2025. 2022 was the busiest year, with 3. The most frequent topics are Autoantibodies, Cells, Cultured and Multiple Sclerosis. Dr. Cuascut has published most often in Biomedicines. Dr. Cuascut's most frequent co-authors are George J. Hutton, MD, Samir Alkabie, MD, MS and Aisha Elfasi, MD.

Dmand AI links Dr. Cuascut to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Multiple Sclerosis, Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease and Autoimmune Diseases of the Nervous System.

CMS Open Payments shows 186 general payments to Dr. Cuascut from 10 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 56% of the total. Horizon Pharma plc paid the most, $21,026. It also lists 2 research payments totaling $1,611 in 2024.

Dr. Cuascut graduated from University of Puerto Rico, Medical Sciences Campus in 2014. Dr. Cuascut is a member of AAN.

Dr. Cuascut is in network with 19 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.